Intensive care medicine
-
Intensive care medicine · Mar 2002
Randomized Controlled Trial Multicenter Study Clinical TrialDobutamine and gastric-to-arterial carbon dioxide gap in severe sepsis without shock.
To evaluate the effect of an early dobutamine infusion on gastrointestinal perfusion in patients with severe sepsis. ⋯ An early infusion of dobutamine at a fixed dose of 5 microg/kg per min during the first 72 h of severe sepsis does not influence gastric DeltaCO2.
-
Intensive care medicine · Mar 2002
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialEvaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study.
To evaluate patient comfort, skin breakdown and eye irritation when comparing a prototype face mask (PM) and conventional face masks (CMs) during non-invasive ventilation. ⋯ The PM significantly reduced skin breakdown while improving patient comfort, compared to the CMs.
-
Intensive care medicine · Mar 2002
Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment.
To examine the time window between injury and treatment during which nebulized corticosteroid lessens lung injury induced by chlorine gas inhalation. ⋯ Treatment with inhaled budesonide immediately or 30 min after chlorine gas lung injury had similar positive effects on symptoms and signs of pulmonary injury, whereas treatment delayed for 60 min was less effective.
-
Intensive care medicine · Mar 2002
Hypoproteinemia as a marker of acute respiratory distress syndrome in critically ill patients with pulmonary edema.
To assess the value of serum protein levels for differentiating permeability pulmonary edema in the course of acute respiratory distress syndrome (ARDS) from cardiogenic pulmonary edema (CPE). ⋯ The data suggest that hypoproteinemia is a marker of ARDS. This may partially reflect increased permeability in the lungs, systemically, or both.